[1] |
Flannery EL, Chatterjee AK, Winzeler EA.Antimalarial drug discovery-approaches and progress towards new medicines[J]. Nat Rev Microbiol, 2017, 15(9): 572.
|
[2] |
WHO Malaria Policy Advisory Committee and Secretaria. Malaria policy advisory committee to the WHO: conclusions and recommendations of september 2012 meeting[J]. Malar J, 2012, 11: 424.
|
[3] |
Assefa A, Ali A, Deressa W, et al. Glucose-6-phosphate dehydrogenase (G6PD) deficiency in Ethiopia: absence of common African and Mediterranean allelic variants in a nationwide study[J]. Malar J, 2018, 17: 388.
|
[4] |
Ashley EA, Recht J, White NJ.Primaquine: the risks and the benefits[J]. Malar J, 2014, 13: 418.
|
[5] |
Gonçalves BP, Tiono AB, Ouédraogo A, et al. Single low dose primaquine to reduce gametocyte carriage and Plasmodium falciparum transmission after artemether-lumefantrinein children with asymptomatic infection: a randomised, double-blind, placebo-controlled trial[J]. BMC Med, 2016, 14: 40.
|
[6] |
Domingo GJ, Satyagraha AW, Anvikar A, et al. G6PD testing in support of treatment and elimination of malaria: recommendations for evaluation of G6PD tests[J]. Malar J, 2013, 12: 391.
|
[7] |
White NJ, Qiao LG, Qi G, et al. Rationale for recommending a lower dose of primaquine as a Plasmodium falciparum gametocytocide in populations where G6PD deficiency is common[J]. Malar J, 2012, 11: 418.
|
[8] |
Kim S, Nguon C, Guillard B, et al. Performance of the CareStartTM G6PD deficiency screening test, a point-of-care diagnostic for pimaquine therapy screening[J]. PLoS One, 2011, 6(12): e28357.
|
[9] |
Von Fricken ME, Weppelmann TA, Eaton WT, et al. Performance of the CareStart glucose-6-phosphate dehydrogenase (G6PD) rapid diagnostic test in Gressier[J]. Haiti Am J Trop Med Hyg, 2014, 91(1): 77-80.
|
[10] |
Adu-Gyasi D, Asante KP, Newton S, et al. Evaluation of the diagnostic accuracy of CareStart G6PD deficiency rapid diagnostic test (RDT) in a malaria endemic area in Ghana, Africa[J]. PLoS One, 2015, 10(4): e0125796.
|
[11] |
Howes RE, Dewi M, Piel FB, et al. Spatial distribution of G6PD deficiency variants across malaria-endemic regions[J]. Malar J, 2013, 12: 418.
|
[12] |
Howes RE, Battle KE, Satyagraha AW, et al. G6PD deficiency: global distribution, genetic variants and primaquine therapy[J]. Adv Parasitol, 2013, 81: 133-201.
|
[13] |
Howes RE, Piel FB, Patil AP, et al. G6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: a geostatistical model-based map[J]. PLoS Med, 2012, 9(11): e1001339.
|
[14] |
Tang TK, Huang CS, Huang MJ, et al. Diverse point mutations result in glucose-6-phosphate dehydrogenase (G6PD) polymor-phism in Taiwan[J]. Blood, 1992, 79(8): 2135-2140.
|
[15] |
Louicharoen C, Patin E, Paul R, et al. Positively selected G6PD-Mahidol mutation reduces Plasmodium vivax density in southeast Asians[J]. Science, 2009, 326(5959): 1546-1549.
|
[16] |
Kuwahata M, Wijesinghe R, Ho MF, et al. Population screening for glucose-6-phosphate dehydrogenase deficiencies in Isabel Province, Solomon Islands, using a modified enzyme assay on filter paper dried bloodspots[J]. Malar J, 2010, 9: 223.
|
[17] |
Vulliamy T, Luzzatto L, Hirono A, et al. Hematologically important mutation: glucosc-6-phosphate dehydrogenase[J]. Blood Cell Molecules Dis, 1997, 23(15): 302-313.
|
[18] |
Filosa S, Fico A, Paglialunga F, et al. Failure to increase glucose consumption through the pentose-phosphate pathway results in the death of glucose-6-phosphate dehydrogenase gene-deleted mouse embryonic stem cells subjected to oxidative stress[J]. Biochem J, 2003, 370(3): 935-943.
|
[19] |
Carter N, Pamba A, Duparc S, et al. Frequency of glucose-6-phosphate dehydrogenase deficiency in malaria patients from six African countries enrolled in two randomized anti-malarial clinical trials[J]. Malar J, 2011, 10: 241.
|
[20] |
Ginsburg H, Atamna H, Shalmiev G, et al. Resistance of glucose-6-phosphate dehydrogenase deficiency to malaria: effects of fava bean hydroxypyrimidine glucosides on Plasmodium falciparum growth in culture and on the phagocytosis of infected cells[J]. Parasitology, 1996, 113(1): 7-18.
|
[21] |
Guindo A, Fairhurst RM, Doumbo OK, et al. X-linked G6PD deficiency protects hemizygous males but not heterozygous females against severe malaria[J]. PLoS Med, 2007, 4(3): e66.
|
[22] |
Goo YK, Ji SY, Shin HI, et al. First evaluation of glucose-6-phosphate dehydrogenase (G6PD) deficiency in vivax malaria endemic regions in the republic of Korea[J]. PLoS One, 2014, 9(5): e97390.
|
[23] |
李华宪, 张再兴, 周新文, 等. 云南省1999-2001年疟疾流行态势分析[J]. 中国寄生虫病防治杂志, 2003, 16(2): 89-92.
|
[24] |
董莹, 孙艾明, 陈梦妮, 等. 云南省输入性及本地感染间日疟原虫裂殖子表面蛋白1基因5区序列的多态性分析[J]. 中国寄生虫学与寄生虫病杂志, 2017, 35(1): 1-7.
|
[25] |
张丽, 丰俊, 张少森, 等. 2017年全国消除疟疾进展及疫情特征分析[J]. 中国寄生虫学与寄生虫病杂志, 2018, 36(3): 201-209.
|
[26] |
中华人民共和国卫生部. 中华人民共和国卫生行业标准(WS259-2015): 疟疾诊断标准[S]. 北京: 人民卫生出版社, 2015: 2-3.
|
[27] |
朱垚吉, 邓艳, 毛祥华, 等. 不同感染来源疟原虫株的18S sRNA基因同源性分析[J]. 中国病原生物学杂志, 2014, 9(4): 331-334.
|
[28] |
Howes RE, Chan ER, Rakotomanga TA, et al. Prevalence and genetic variants of G6PD deficiency among two Malagasy populations living in Plasmodium vivax-endemic areas[J]. Malar J, 2017, 16: 139.
|
[29] |
Kießling N, Brintrup J, Zeynudin A, et al. Glucose-6-phosphate dehydrogenase activity measured by spectrophotometry and associated genetic variants from the Oromiya zone, Ethiopia[J]. Malar J, 2018, 17: 358.
|
[30] |
Minucci A, Moradkhani K, Hwang MJ, et al. Glucose-6-phosphate dehydrogenase (G6PD) mutations database: review of the “old” and update of the new mutations[J]. Blood Cell Mol Dis, 2012, 48(3): 154-165.
|
[31] |
Lander ES, Linton LM, Birren B, et al. Initial sequencing and analysis of the human genome[J]. Nature, 2001, 409(6822): 860-921.
|
[32] |
Dombrowski JG, Souza RM, Curry J, et al. G6PD deficiency alleles in a malaria-endemic region in the western Brazilian Amazon[J]. Malar J, 2017, 16: 253.
|
[33] |
Beutler E.Glucose-6-phosphate dehydrogenase deficiency: a historical perspective[J]. Blood, 2008, 111(1): 16-24.
|
[34] |
Shah SS, Macharia A, Makale J, et al. Genetic determinants of glucose-6-phosphate dehydrogenase activity in Kenya[J]. BMC Med Genet, 2014, 15: 93.
|
[35] |
Gómez-Manzo S, errón-Hernández J, de la Mora-de la Mora I, et al. TCloning, expression, purification and characterization of His-tagged human glucose-6-phosphate dehydrogenase: a simplified method for protein yield[J]. Protein J, 2013, 32(7): 585-592.
|
[36] |
Jiang W, Yu G, Liu P, et al. Structure and function of glucose-6-phosphate dehydrogenase-deficient variants in Chinese population[J]. Hum Genet, 2006, 119(5): 463-478.
|
[37] |
Li Q, Yang F, Liu R, et al. Prevalence and molecular characterization of glucose-6-phosphate dehydrogenase deficiency at the China-Myanmar border[J]. PLoS One, 2015, 10(7): e0134593.
|
[38] |
潘小莉, 庄丹燕, 陈怡博, 等. 宁波地区273例G6PD缺乏症基因突变类型分析[J]. 中国优生与遗传杂志, 2017, 25(5): 37-39.
|
[39] |
Levy HR.Glucose-6-phosphate dehydrogenases[J]. Adv Enzymol Relat Areas Mol Biol, 1979, 48: 97-192.
|
[40] |
Au SW, Gover S, Lam VM, et al. Human glucose-6-phosphate dehydrogenase: the crystal structure reveals a structural NADP+ molecule and provides insights into enzyme deficiency[J]. Structure, 2000, 8(3): 293-303.
|
[41] |
Au SW, Naylor CE, Gover S, et al. Solution of the structure of tetrameric human glucose-6-phosphate dehydrogenase by molecular replacement[J]. Acta Crystallogr D Biol Crystallogr, 1999, 55(4): 826-834.
|
[42] |
Cohen P, Rosemeyer MA.Subunit interactions of glucose-6-phosphate dehydrogenase from human erythrocytes[J]. Eur J Biochem, 1969, 8(1): 8-15.
|